
Opinion|Podcasts|September 4, 2024
Multisymptomatic Care in Parkinson's Disease
Key Takeaways
- Optimizing PD treatment involves using levodopa and adjunct therapies to address patient-specific and pharmacologic challenges effectively.
- Coordinated care among healthcare providers is essential for comprehensive PD treatment strategies.
Stuart Isaacson, MD, Rajesh Pahwa, MD, and Jennifer Goldman, MD discuss optimizing PD treatment with levodopa and adjunct therapies, addressing patient and pharmacologic challenges, coordinating care, and anticipating the impact of emerging therapies and upcoming Medicare Part D changes.
Advertisement
Multisymptomatic Care in Parkinson's Disease
Stuart Isaacson, MD, Rajesh Pahwa, MD, and Jennifer Goldman, MD discuss optimizing PD treatment with levodopa and adjunct therapies, addressing patient and pharmacologic challenges, coordinating care, and anticipating the impact of emerging therapies and upcoming Medicare Part D changes.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Advisory Committee Votes Against Deramiocel for DMD Cardiomyopathy
2
Weighing Disease-Modifying Therapy Discontinuation in Older, Stable Patients With MS
3
The Future of Alzheimer Disease Care: Toward Biomarker-Guided Personalized Treatment
4
FDA AdComm Votes Against Recommending Deramiocel Approval, Tazbentetol Shows Durable Cognitive Benefit in AD, Salanersen's FDA Breakthrough Designation Meaning
5

















